From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory de...
What a brutal six months it’s been for Avantor. The stock has dropped 30.3% and now trades at $7.66, rattling many shareholders. This might have investors co...
Avantor's first quarter results were met with a negative market reaction, as investors focused on persistent margin pressures and flat revenue growth. Manage...
Life sciences company Avantor (NYSE:AVTR) announced better-than-expected revenue in Q1 CY2026, but sales were flat year on year at $1.58 billion. Its non-GAA...
Life sciences company Avantor (NYSE:AVTR) reported Q1 CY2026 results beating Wall Street’s revenue expectations, but sales were flat year on year at $1.58 bi...
Life sciences company Avantor (NYSE:AVTR) will be reporting earnings this Wednesday before market hours. Here’s what to expect. Avantor beat analysts’ revenu...
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the research tools & consumables industry, including Avantor (NYS...
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ...
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a co...
What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in...
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic...
Avantor has gotten torched over the last six months - since September 2025, its stock price has dropped 38% to a new 52-week low of $7.88 per share. This may...
What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea...
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have...
